Similar to the findings in COPD, tumor infiltrating CD14+ cells in patients with early lung cancer express a mixture of FcγRs (CD64, CD32), cytokine receptors (CD115) and scavenger receptors (CD163, CD206). The gene discussed is CD14; the disease is neoplasm.